In the global medical devices industry, there were 145 M&A deals announced in Q2 2023, worth a total value of $6.1bn, according to GlobalData’s Deals Database. The $1.8bn acquisition of spectrum plastics group by dupont de nemours was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, M&A activity decreased by 12% in Q2 2023 compared with the previous quarter’s total of $6.9bn and fell by 4% as compared to Q2 2022. Related deal volume decreased by 6% in Q2 2023 versus the previous quarter and was 16% lower than in Q2 2022.
Notably, foreign direct investments (fdi)-related deals accounted for a 39% share of the global medical devices industry’s M&A activity in Q2 2023, up 13% over the previous quarter.
The top-ranked financial advisors supporting these M&A deals in Q2 2023 were UBS Group; Piper Sandler Companies; Stifel Financial with 5, 4, 4 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Q2 2023 were CMS Legal Services EEIG; Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates; Baker & McKenzie with 6, 5, 4 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.